# BIOCEPT INC (BIOCQ)

> Institutional ownership reported to the SEC as of Q3 2023, from Form 13F filings. Source: https://holderbook.com/stocks/BIOCQ/

- Reporting holders: 12
- Reported value: $218.0K
- Held through calls: 0.0%
- Held through puts: 0.0%

A 13F reports long US equity positions only. Shorts, bonds, foreign listings and cash are not visible here, and positions are disclosed up to 45 days after the quarter ends.

## Largest holders

| Manager | Value | Shares | Share of their book | Quarters held |
|---|---|---|---|---|
| [Alyeska Investment Group, L.P.](https://holderbook.com/funds/1453072-alyeska-investment-group-l-p/) | $147.1K | 117,647 | 0.0% | 1 |
| [Virtu Financial LLC](https://holderbook.com/funds/1533964-virtu-financial-llc/) | $17.0K | 13,777 | 0.0% | 1 |
| [TWO SIGMA SECURITIES, LLC](https://holderbook.com/funds/1450144-two-sigma-securities-llc/) | $15.9K | 12,718 | 0.0% | 1 |
| [GEODE CAPITAL MANAGEMENT, LLC](https://holderbook.com/funds/1214717-geode-capital-management-llc/) | $13.1K | 10,504 | 0.0% | 1 |
| [SUSQUEHANNA INTERNATIONAL GROUP, LLP](https://holderbook.com/funds/1446194-susquehanna-international-group-llp/) | $13.0K | 10,406 | 0.0% | 1 |
| [BlackRock Inc.](https://holderbook.com/funds/1364742-blackrock-inc/) | $6.6K | 5,261 | 0.0% | 2 |
| [Tower Research Capital LLC (TRC)](https://holderbook.com/funds/1533421-tower-research-capital-llc-trc/) | $4.8K | 3,802 | 0.0% | 2 |
| [GROUP ONE TRADING, L.P.](https://holderbook.com/funds/932540-group-one-trading-l-p/) | $338 | 270 | 0.0% | 2 |
| [UBS Group AG](https://holderbook.com/funds/1610520-ubs-group-ag/) | $155 | 124 | 0.0% | 1 |
| [OSAIC HOLDINGS, INC.](https://holderbook.com/funds/1677044-osaic-holdings-inc/) | $41 | 33 | 0.0% | 2 |
| [US BANCORP \DE\](https://holderbook.com/funds/36104-us-bancorp-de/) | $23 | 18 | 0.0% | 2 |
| [WELLS FARGO & COMPANY/MN](https://holderbook.com/funds/72971-wells-fargo-company-mn/) | $14 | 11 | 0.0% | 2 |

## Quarter by quarter

| Quarter | Holders | Reported value |
|---|---|---|
| Q3 2023 | 12 | $218.0K |
| Q2 2023 | 9 | $96.4K |
| Q4 2022 | 1 | $10.0K |
| Q3 2022 | 2 | $12.0K |
| Q2 2022 | 2 | $36.0K |
| Q1 2022 | 2 | $124.0K |
| Q4 2021 | 2 | $31.0K |
| Q3 2021 | 2 | $61.0K |
| Q2 2021 | 3 | $587.0K |
| Q1 2021 | 3 | $937.0K |
| Q4 2020 | 2 | $236.0K |